Brief: Adaptimmune Reports Fourth Quarter And Full Year 2021 Financial Results And Business Update
14/03/2022 12:13
March 14 (Reuters) - Adaptimmune Therapeutics PLC ADAP.O :
* ADAPTIMMUNE REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS AND BUSINESS UPDATE
* QTRLY LOSS PER SHARE $0.04
* ADAPTIMMUNE THERAPEUTICS - BELIEVES EXISTING CASH, CASH
EQUIVALENTS AND MARKETABLE SECURITIES TO FUND CURRENT OPERATIONS
INTO EARLY 2024
Source text for Eikon: ID:nGNX9WL3Q5
Further company coverage: ADAP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptimmune Therapeutics
See all newsAdaptimmune Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 10 cents a share - Earnings Preview
Enters Settlement Agreement With MD Anderson - SEC Filing
Adaptimmune Therapeutics PLC reports results for the quarter ended March 31 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 12 cents a share - Earnings Preview